Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Forging a New Path into the Medical Cannabis Space

Although 2019 was in many ways ‘The Year that the Cannabis Sector Would Like to Forget’, there are many pioneering ways that a company can take to generate revenue in the still-emerging medical cannabis and CBD markets. One such company has been advancing st...
Dave Jackson | February 13, 2020 |

This Canadian Biopharmaceutical Co. is a Pioneer of the Medical Cannabis Industry

An evidence-based, scientific approach is how Avicanna Inc. ( TSX.AVCN , OTC: AVCNF , Forum ) gains its competitive advantage in the medical cannabis sector. The Canadian biopharmaceutical company has spent over four years in research & development before creating its m...
Isabella Zavarise | December 22, 2020 |

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
Marc Davis | January 8, 2020 |

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Co

Aethlon Medical CEO Jim Joyce Discusses the Forthcoming 'Concussion' Movie and CTE Research Being Conducted by Aethlon's Exosome Sciences Subsidiary Source: Gail Dutton of The Life Sciences Report (12/22/15) https://www.thelifesciencesreport.com/pub/na/aethlon-medical...
Gail Dutton | December 23, 2015 |

PODCAST: A CBD-focused First-to-Market Franchise Model

This podcast is part of our Cannabis Sector CEO interview series. The focus of our new StockTalk Podcasts is to help listeners and investors learn about, understand, and discover investment opportunities in the public marketplace.   Stockhouse Media's Dave Jackson was r...
Dave Jackson | September 19, 2019 |

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

Varian Shares Trade Higher on Yearly Earnings and FY/20 Guidance

Shares of Varian Medical Systems traded 10% higher at times today after the company reported quarterly and annual earnings. The company increased revenue 10% year-over-year and provided FY/20 guidance. Yesterday afternoon medical device maker Varian Medical Systems I...
Streetwise Reports | October 26, 2019 |

An Emerging Medical Market Play with Great Opportunity

(Image via Bioasis Technologies Inc.) Biopharmaceutical Company Bioasis Technologies Inc. ( TSX-V: BTI , OTCQB: BIOAF , Forum ) is developing its proprietary xB 3TM platform technology to deliver therapeutics across the blood brain barrier (BBB) and int...
Stockhouse Editorial | July 28, 2020 |

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...
Streetwise Reports | June 22, 2020 |

This Medical Device Company Plans to Grow its Business Through M&A

(Click image to watch video) North America is one of the hottest spots for the medical device industry, having accounted for nearly half of all market revenue in 2019. According to a report , medical devices continue to rise in importance for disease preventio...
Jocelyn Aspa | June 10, 2021 |
1 2 3 4 5 6 7 8 9 10 ...